Transfusion Support and Red Cell Alloimmunisation in Thalassemia Patients
Journal Title: Haematology International Journal - Year 2018, Vol 2, Issue 2
Abstract
Thalassemias are the most common mono genetic disease worldwide. It has high frequency extending from the Mediterranean basin through the Middle East (Iran), India and Southeast Asia. In India, the carrier rate of Beta Thalassemia varies from 3-17%.
Authors and Affiliations
Dibyajyoti Sahoo
Keywords
Related Articles
- EP ID EP291064
- DOI -
- Views 79
- Downloads 0
The Epidemiology of Leukaemia in Zimbabwe: A Ten Year Retrospective Study
1.1. Background: Haematological malignancies are defined as primary cancers of blood cells. Leukaemia constitutes more than fifty-five percent of haematological malignancies. The epidemiology of leukaemia in Zimbabwe is...
Cost-Effectiveness of Idelalisib-Rituximab for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
1.1. Background: A significant survival prolongation was recently reported by adding idelalisib to rituximab (IR) compared with rituximab (R) in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL). No...
The Stellar, Astral Reproduction: Burkitt ‘S Lymphoma
An infrequent (≤1.2%), aggressive B lymphocyte non hodgkin’s lymphoma is designated as a Burkitt’s lymphoma, which may present as an extra-nodal tumefaction or as an acute leukaemia [1]. A well delineated clinico-patholo...
Surface and Interacellular Targets of Acute Myeloid Leukemia Therapy Detectable at Leukemic Stem Cell level
For over 50 years investigators have considered a malignant stem cell as the potential origin of and a key therapeutic target for acute myeloid leukaemia (AML) and other forms of cancer [1]. Leukaemic stem cells (LSCs) h...
Physicians’ Opinion on the Practice of Exchange Blood Transfusion for Treatment of Stroke in Sickle Cell Anaemia
1.1. Background: The current most effective preventive as well as therapeutic modality for stroke in sickle cell anaemia (SCA) is the use of exchange blood transfusion (EBT) in a chronic transfusion program. The challeng...